Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy

Masahiko Takahashi, Hidetsugu Saito, Makiko Higashimoto, Kazuhiro Atsukawa, Hiromasa Ishii

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences